175P - Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)
| Autor: | Shitara, K., Tabernero, J., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., Zhavrid, E., Nishikawa, K., Hosokawa, A., Ganea, D., Yalçın, Ş., Fujitani, K., Beretta, G., Winkler, R., Doi, T., Ilson, D.H. |
|---|---|
| Zdroj: | In Annals of Oncology November 2018 29 Supplement 9:ix55-ix55 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|